Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 3]
Pharmac To Supply Overdose Reversing Medicine Naloxone To Needle Exchange Sites
Thursday, 21 December 2023, 11:14 am | PHARMAC
Te Pātaka Whaioranga – Pharmac is pleased to confirm that naloxone injections will now be supplied to the New Zealand Needle Exchange Programme, to ensure it is available in the community to treat opioid overdoses. “Naloxone quickly reverses ... More >>
Pharmac Proposes To Fund Treatments For Breast And Blood Cancer
Tuesday, 12 December 2023, 3:04 pm | PHARMAC
Pharmac – Te Pātaka Whaioranga is seeking feedback on a proposal to fund two new treatments for advanced breast cancer and a type of blood cancer. The treatments, ribociclib (branded as Kisqali) and midostaurin (branded as Rydapt), are part of ... More >>
Pharmac Making Progress On Action Plan To Enhance Organisational Culture
Friday, 1 December 2023, 2:49 pm | PHARMAC
Pharmac is making progress to enhance the organisational culture with all immediate tasks in the action plan either completed or underway. Pharmac's chief executive and senior leadership team provided an update on the implementation of the action ... More >>
Pharmac Celebrates Pacific Excellence At SunPix Pacific Peoples Awards
Thursday, 16 November 2023, 3:39 pm | PHARMAC
Te Pātaka Whaioranga – Pharmac is honoured to have been able to help celebrate leadership and excellence in Pacific communities at the 2023 SunPix Pacific Peoples Awards in Auckland. This annual event is the largest Pacific people's awards ceremony ... More >>
Pharmac Calls For Applications For Medicines For Rare Disorders
Monday, 13 November 2023, 11:00 am | PHARMAC
Te Pātaka Whaioranga – Pharmac is calling for applications for medicines to treat rare disorders. These will be considered at the next meeting of the Rare Disorders Advisory Committee meeting in May 2024. “We are encouraging funding applications ... More >>
Pharmac Proposing To Fully Fund Testosterone Gel For All Who Need It
Wednesday, 8 November 2023, 3:56 pm | PHARMAC
Te Pātaka Whaioranga – Pharmac is consulting on a proposal to fund testosterone gel without restrictions as an additional testosterone treatment for those who need it. Testosterone gel is used as a hormone replacement for men who can’t produce ... More >>
Pharmac Board Endorse Action Plan To Improve Organisational Culture
Friday, 27 October 2023, 4:03 pm | PHARMAC
At Pharmac’s regular monthly Board meeting held today, the Board endorsed the action plan proposed by the chief executive and senior leadership team to improve the organisation’s culture. The action plan is in response to unprofessional comments ... More >>
Access To COVID-19 Antiviral Treatments Widened For More People At Risk
Wednesday, 20 September 2023, 11:02 am | PHARMAC
Te Pātaka Whaioranga – Pharmac is widening access to COVID-19 antivirals to people who are vulnerable to severe infection from COVID-19, including those with disabilities and with one or more severe health conditions. “We know antivirals can reduce the ... More >>
Pharmac Widens Access To Treatment For Life-long Bleeding Disorder, Severe Haemophilia A
Monday, 4 September 2023, 11:26 am | PHARMAC
Te Pātaka Whaioranga – Pharmac has confirmed it is widening access to emicizumab (branded as Hemlibra) for the treatment of people with severe haemophilia A without factor VIII inhibitors. “Widening access to this treatment will help people manage ... More >>
Pharmac Funds First Treatment For Primary Progressive Multiple Sclerosis
Monday, 4 September 2023, 11:12 am | PHARMAC
Te Pātaka Whaioranga – Pharmac has confirmed it is widening access to ocrelizumab (branded as Ocrevus) as the first funded treatment for primary progressive multiple sclerosis. “We’re pleased to have a treatment option for people living with primary ... More >>
Pharmac Taking Action To Ensure Supply Of Type 2 Diabetes Medicine Amid Worldwide Shortage
Tuesday, 29 August 2023, 2:45 pm | PHARMAC
Te Pātaka Whaioranga - Pharmac is taking steps to ensure people with type 2 diabetes who take dulaglutide (branded as Trulicity) can continue to access the treatment while we experience further supply chain issues on top of a global shortage. Dulaglutide ... More >>
Pharmac Seeking Bids From Suppliers For Multiple Myeloma Treatments
Thursday, 24 August 2023, 2:00 pm | PHARMAC
Te Pātaka Whaioranga - Pharmac is seeking bids from suppliers for two medicines, lenalidomide and pomalidomide, for use in the treatment of multiple myeloma. “We understand there is a high unmet health need for people with multiple myeloma,” ... More >>
Pharmac Confirms Transition To A Trastuzumab Biosimilar And Widens Access To Other Types Of Cancer
Wednesday, 23 August 2023, 1:48 pm | PHARMAC
Te Pātaka Whaioranga – Pharmac is transitioning to a trastuzumab biosimilar, Herzuma, from the currently funded brand, Herceptin, as a result of a competitive procurement process. The treatment is currently funded for people with metastatic ... More >>
Pharmac Calls For Applications From The Suppliers Of Vaccines That Protect Against COVID-19
Wednesday, 16 August 2023, 12:59 pm | PHARMAC
Te Pātaka Whaioranga – Pharmac is interested to hear from pharmaceutical suppliers who manufacture vaccines that protect against COVID-19 and offer the opportunity to submit funding applications for future consideration. “Pharmac is now responsible ... More >>
Pharmac Indicates Interest To Fund More Oestradiol Treatments To Relieve Supply Issue
Tuesday, 15 August 2023, 6:30 am | PHARMAC
Te Pātaka Whaioranga - Pharmac is planning to issue a competitive process for supply of oestradiol transdermal products in New Zealand. “Today we have issued a Future Procurement Opportunity for oestradiol transdermal products,” says Pharmac’s ... More >>
Pharmac Proposes Widening Access To A Brain Cancer Treatment To Help Reduce The Impact Of A Discontinuation
Friday, 11 August 2023, 9:06 am | PHARMAC
Te Pātaka Whaioranga – Pharmac is proposing to widen access to temozolomide, an oral anti-cancer treatment, for people with a type of brain cancer called glioma. This comes as lomustine, the current treatment option for people with low grade or ... More >>
Pharmac’s Rare Disorders Advisory Committee Makes New Recommendations For Funding
Thursday, 10 August 2023, 12:58 pm | PHARMAC
Te Pātaka Whaioranga – Pharmac has published the record of the March Rare Disorders Advisory Committee meeting, sharing details on a number of funding applications including those for spinal muscular atrophy (SMA). The Rare Disorders Advisory Committee meeting ... More >>
Pharmac Secures Supply Of Vaccines For New Zealanders
Thursday, 3 August 2023, 12:59 pm | PHARMAC
Te Pātaka Whaioranga – Pharmac has confirmed supply agreements for a range of funded vaccines including those that protect against influenza and meningococcal disease. This follows a request for proposals (RFP) competitive process. “We are ... More >>
Pharmac Considers Access Criteria For COVID-19 Antiviral Treatments
Tuesday, 1 August 2023, 2:58 pm | PHARMAC
Te Pātaka Whaioranga – Pharmac is consulting on changes to the access criteria for all COVID-19 antiviral treatments to include more people who are at risk of becoming severely ill from the infection. “We now know that these antiviral treatments can ... More >>
Pharmac Joins International Collaboration To Advance Use Of Health Technology Assessments
Thursday, 20 July 2023, 1:05 pm | PHARMAC
Pharmac has joined an international collaboration of government health technology assessment (HTA) agencies. Together with partners from Australia, the United Kingdom and Canada we're working to make health systems better by sharing HTA knowledge and ... More >>
